Clinical Trial Update: A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers [Phase 1]

View source ↗

Summary

This update notes the completion of a Phase 1 safety study of TG100801 Eye Drops in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy

Drugs mentioned

• TG100801 Eye Drops (TG100801)

Snippet

Sponsor: TargeGen | Conditions: Macular Degeneration, Diabetic Retinopathy | Phase 1 | Status: COMPLETED